Ironwood Pharmaceuticals (IRWD) Exchange Rate Effect (2023 - 2026)
Ironwood Pharmaceuticals (IRWD) reported Exchange Rate Effect of -$106000.0 for Q1 2026, down 1414.29% on a YoY basis from $8065.2 in Q1 2025, and down 130.2% sequentially from $351000.0 in Q4 2025.
Ironwood Pharmaceuticals (IRWD) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Ironwood Pharmaceuticals (IRWD) has 4 years of Exchange Rate Effect data on file, last reported at -$106000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 1414.29% year-over-year to -$106000.0; the trailing twelve-month figure through Mar 2026 stood at -$428000.0 (down 579.37% YoY), and the FY2025 full-year result was -$329000.0, down 928.12% from the prior year.
- Exchange Rate Effect fell to -$106000.0 in Q1 2026, from $351000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $351000.0 in Q4 2025 to a low of -$647000.0 in Q2 2025.
- A 4-year average of -$51700.0 and a median of -$26000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect surged 1571.43% in 2025 and plunged 1414.29% in 2026, its largest moves.
- Tracing IRWD's Exchange Rate Effect over 4 years: stood at -$50000.0 in 2023, then surged by 142.0% to $21000.0 in 2024, then soared by 1571.43% to $351000.0 in 2025, then tumbled by 130.2% to -$106000.0 in 2026.
- Business Quant data shows IRWD's Exchange Rate Effect at -$106000.0 in Q1 2026, $351000.0 in Q4 2025, and -$26000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Ironwood Pharmaceuticals | 619.48 Mn | 399.01 Mn | - | -106,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106,000.00 |
| Mar 31, 2026 | -106,000.00 |
| Dec 31, 2025 | 351,000.00 |
| Dec 31, 2025 | 351,000.00 |
| Sep 30, 2025 | -26,000.00 |
| Sep 30, 2025 | -26,000.00 |
| Jun 30, 2025 | -647,000.00 |
| Jun 30, 2025 | -647,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | -26,000.00 |
| Sep 30, 2024 | -26,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | -50,000.00 |
| Dec 31, 2023 | -50,000.00 |